Sartorius AG (SUVPF)
Sartorius AG operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Göttingen, NI, DE. The stock last traded at $270.29, up 0.00% on the session, giving a market capitalisation of $18.66B. On trailing twelve-month figures it carries a trailing P/E of 83.39, a net margin of 4.8%. Its beta of 1.46 implies it has historically moved more than the broad market.
Sartorius AG, a German company established in 1870 and based in Göttingen, is a global supplier of innovative bioprocess solutions and laboratory products and services. The company's extensive portfolio supports life science research, biopharmaceutical manufacturing, quality control, and other applied industries worldwide. Its offerings encompass a wide array of sophisticated tools and consumables, including: Advanced Analytics: Biosensors, label-free detection, and SPR systems; live-cell analysis platforms, flow cytometry, and related reagents. Cell Culture and Fermentation: Various bioreactors (e.g., single-use, stainless steel, benchtop) along with specialized media (for antibodies, recombinant proteins, stem cells, viral vaccines) and other essential reagents like buffers and microcarriers. Filtration and Separation: A comprehensive range of membranes, filter papers, syringe filters, and diverse filtration and ultrafiltration devices for sterile processing, sample preparation, and clarification. Laboratory Essentials: Weighing and pipetting systems, centrifuges, industrial microbiology systems, and water purification units. Process Solutions: Fluid management, process chromatography, and advanced analytical technologies coupled with data analytics. Beyond products, Sartorius provides crucial support services such as bioprocess development and engineering, protein expression system services, media and process optimization, testing, instrument services, and validation assistance.
Sartorius AG is most often compared with the following Healthcare names: